Pharma and biotech have developed amazing therapies and treatments to help people living with cancer. But effective cancer care should be more than just chemo and an effective drug. 

Exercise and wellness can help. A lot.

What role should pharmaceutical manufacturers and market access teams play in exercise and wellness for cancer patients though? Do they incorporate exercise? Isn’t their cancer-fighting drug enough? 

Today’s guests believe pharma and market access should factor in exercise and wellness when treating cancer. And they’ll explain how pharma and market access can take all this into consideration.

John Hennessy is a principal with Valuate Health. He’s been on The IDI many times and he’s held many roles in the world of oncology and cancer care.

First-time IDI guest Sami Mansfield is the founder of Cancer Wellness for Life, an organization focused on developing oncology exercise resources for individuals, hospitals, and corporations. She’s been in this space for more than 20 years and was one of the first oncology exercise specialists in the United States.

Here are just a few research findings about the benefits of wellness and exercise on cancer care patients, including two articles co-authored by Sami Mansfield. 

Follow Valuate on LinkedIn or visit us at ValuateHealth.com.